The Medicines Company to Announce Third-Quarter 2018 Financial Results on November 8

01 Nov 2018
The Medicines Company to announce third-quarter 2018 financial results and operational developments 8 Nov 2018 at 8:30 AM EST.

The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Thursday, November 8, 2018, at 8:30 a.m., EST, to discuss its third-quarter 2018 financial results and operational developments.

The conference call may be accessed by telephone as follows:

U.S./Canada: (877) 407-0312

International: (201) 389-0905

Conference ID: 13684654

A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:

U.S./Canada: (877) 660-6853

International: (201) 612-7415

Conference ID: 13684654

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website. An archived webcast will be available after the call concludes.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s goal is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians, and providers in cardiovascular care. The Company is headquartered in Parsippany, New Jersey.

$MDCO to announce #Q32018 financial results on 08 Nov 2018 @ 8:30AM EST #savethedate #earnings #inclisiran #PCSK9 #lipids

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information

Human Resources
Verification of employment
Tel 973 290 6361
Fax 862 207 6361

Investors Relations

Krishna Gorti, MD
Tel 973 290 6122
krishna.gorti@themedco.com

Media Inquiries

Michael Blash
Tel 973 290 6100
michael.blash@themedco.com